SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
225Report available here in PDF - drugroyalty.com I'll get around to looking nigel bates-1/17/2002
224They keep saying "strong cash flow". Would be interested in how stronkeokalani'nui-1/17/2002
223Looks a decent enough deal to me at first glance - particularly as DRC have a ronigel bates-1/17/2002
222Cambridge Antibody Technology ('CAT') And Drug Royalty Corporation ('nigel bates-1/17/2002
221Summary of HnQ. Thank you Nigel! Message 16910361keokalani'nui-1/15/2002
220Another announcement I missed while Air France were losing my luggage... MELBOUnigel bates-1/15/2002
219First agonist Humab into clinicals ? MELBOURN, England, and ROCKVILLE, Md., Jannigel bates-1/15/2002
218The PRs - MELBOURN, England and PALO ALTO, Calif., Dec. 19 /PRNewswire/ -- Cambrnigel bates-12/19/2001
217New deals: Message 16809430 Cheers, Tucktuck-12/19/2001
2166-k filed 11/28. Makes good reading. sec.govkeokalani'nui-12/6/2001
215Financial Review The following review is based on the Group's consolidated fnigel bates-11/26/2001
214MELBOURN, England, Nov. 26 /PRNewswire/ -- Highlights 1. Six CAT-denigel bates-11/26/2001
213<i>I bailed for a small, nerve-wracking gain on its recovery to $27.5 a conigel bates-11/17/2001
212About the only difference I can see versus the three month results are more evidtuck-11/16/2001
211Why is CAT so stubborn about this indication? Or do I just not see the obvious?keokalani'nui-11/14/2001
210MELBOURN, England, Nov. 14 /PRNewswire/ -- Cambridge Antibody Technology (Nasdaqnigel bates-11/14/2001
209Genzyme General and Cambridge Antibody Technology Initiate Phase 1-2 Clinical Trnigel bates-11/12/2001
208Message 16633135 <i>TACI-Ig, a soluble recombinant receptor developed by Znigel bates-11/9/2001
207Human Genome Sciences Initiates Trial of a New Drug for Systemic Lupus Erythematnigel bates-11/1/2001
206Cambridge Antibody Technology Announces Product Development Alliance With Merck nigel bates-10/10/2001
205MELBOURN, England, Sept. 25 /PRNewswire/ -- Cambridge Antibody Technology (Nasdanigel bates-9/25/2001
204Very good. Justice!! (eom)scaram(o)uche-9/19/2001
203Cambridge Antibody Technology Announces Grant of Antibody Expression Library Patnigel bates-9/19/2001
202MELBOURN, England, Aug. 22 /PRNewswire/ -- Cambridge Antibody Technology (Nasdaqnigel bates-8/22/2001
201MELBOURN, England, Aug. 21 /PRNewswire/ -- Cambridge Antibody Technology (Nasdaqnigel bates-8/21/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News